Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Thrombocytopenia 4Leukemia, Myeloid, Acute 4Leukemia 3Sarcoma 1Recurrence 1Pathologic Complete Response 1Osteosarcoma 1Neoplasms, Connective and Soft Tissue 1Multiple Myeloma 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Erythroblastic, Acute 1Leukemia, Eosinophilic, Acute 1Leukemia, Basophilic, Acute 1Jacobs syndrome 1Congenital Abnormalities 1Bone Neoplasms 1

Interventions

fludarabine phosphate 16Peripheral Blood Stem Cell Transplantation 14Cytarabine 12Cyclophosphamide 12Whole-Body Irradiation 10Filgrastim 9Cyclosporine 9Busulfan 9Mycophenolic Acid 8Tacrolimus 7Etoposide 7Antilymphocyte Serum 7Radiotherapy 6Methotrexate 6Granulocyte Colony-Stimulating Factor 6Cord Blood Stem Cell Transplantation 6Methylprednisolone 5Flow Cytometry 5Thiotepa 4Mitoxantrone 4Melphalan 4Idarubicin 4Decitabine 4fludarabine 3aldesleukin 3Transplantation 3Interleukin-2 3Bortezomib 3Alemtuzumab 3Vorinostat 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Congenital Abnormalities × eltrombopag × Clear all
NCT01550185 2022-07-22

Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia

Roswell Park Cancer Institute

Phase 1 Terminated
10 enrolled
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡